The analyst might have been a bit too bullish on Nucleus Software Exports Limited (NSE:NUCLEUS), given that the company fell short of expectations when it released its first-quarter results last week. Results showed a clear earnings miss, with ₹2.1b revenue coming in 8.9% lower than what the analystexpected. Statutory earnings per share (EPS) of ₹9.07 missed the mark badly, arriving some 33% below what was expected. The analyst typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimate suggests is in store for next year.
Taking into account the latest results, the most recent consensus for Nucleus Software Exports from one analyst is for revenues of ₹9.22b in 2027. If met, it would imply a satisfactory 6.1% increase on its revenue over the past 12 months. Per-share earnings are expected to jump 39% to ₹55.50. Before this earnings report, the analyst had been forecasting revenues of ₹9.50b and earnings per share (EPS) of ₹57.70 in 2027. The analyst are less bullish than they were before these results, given the reduced revenue forecasts and the minor downgrade to earnings per share expectations.
Check out our latest analysis for Nucleus Software Exports
The consensus price target fell 17% to ₹1,000, with the weaker earnings outlook clearly leading valuation estimates.
Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that Nucleus Software Exports' revenue growth is expected to slow, with the forecast 8.2% annualised growth rate until the end of 2027 being well below the historical 13% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 11% per year. Factoring in the forecast slowdown in growth, it seems obvious that Nucleus Software Exports is also expected to grow slower than other industry participants.
The Bottom Line
The biggest concern is that the analyst reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Nucleus Software Exports. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. The consensus price target fell measurably, with the analyst seemingly not reassured by the latest results, leading to a lower estimate of Nucleus Software Exports' future valuation.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have analyst estimates for Nucleus Software Exports going out as far as 2028, and you can see them free on our platform here.
You still need to take note of risks, for example - Nucleus Software Exports has 2 warning signs we think you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.